{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:05:54Z","timestamp":1792029954553,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2020YFA0804500"],"award-info":[{"award-number":["2020YFA0804500"]}]},{"name":"National Key Research and Development Program of China","award":["2020YFA0804501"],"award-info":[{"award-number":["2020YFA0804501"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071967"],"award-info":[{"award-number":["82071967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22022601"],"award-info":[{"award-number":["22022601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402335"],"award-info":[{"award-number":["82402335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-070"],"award-info":[{"award-number":["2022-PUMCH-B-070"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-071"],"award-info":[{"award-number":["2022-PUMCH-B-071"]}]},{"name":"Shanghai Medical Innovation & Development Foundation","award":["Shanghai Medical Innovation & Development Foundation"],"award-info":[{"award-number":["Shanghai Medical Innovation & Development Foundation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00259-025-07233-y","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T09:03:46Z","timestamp":1743843826000},"page":"3557-3566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The diagnostic performance of [18F]Florbetazine in Alzheimer\u2019s disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir"],"prefix":"10.1007","volume":"52","author":[{"given":"Meiqi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-083X","authenticated-orcid":false,"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"7233_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"key":"7233_CR2","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"key":"7233_CR3","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement"},{"key":"7233_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","volume":"83","author":"J Cummings","year":"2023","unstructured":"Cummings J. Anti-Amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics. Drugs. 2023;83:569\u201376. https:\/\/doi.org\/10.1007\/s40265-023-01858-9.","journal-title":"Drugs"},{"key":"7233_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The role of amyloid PET in imaging neurodegenerative disorders: A review. J Nucl Med. 2022;63:S13\u20139. https:\/\/doi.org\/10.2967\/jnumed.121.263195.","journal-title":"J Nucl Med"},{"key":"7233_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319. https:\/\/doi.org\/10.1002\/ana.20009.","journal-title":"Ann Neurol"},{"key":"7233_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00259-012-2088-x","volume":"39","author":"VL Villemagne","year":"2012","unstructured":"Villemagne VL, Mulligan RS, Pejoska S, et al. Comparison of 11\u00a0C-PiB and 18F-florbetaben for A\u03b2 imaging in ageing and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2012;39:983\u20139. https:\/\/doi.org\/10.1007\/s00259-012-2088-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7233_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00259-013-2564-y","volume":"41","author":"S Hatashita","year":"2014","unstructured":"Hatashita S, Yamasaki H, Suzuki Y, Tanaka K, Wakebe D, Hayakawa H. [18F]Flutemetamol amyloid-beta PET imaging compared with [11\u00a0C]PIB across the spectrum of Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2014;41:290\u2013300. https:\/\/doi.org\/10.1007\/s00259-013-2564-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7233_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.112.109009","volume":"54","author":"SM Landau","year":"2013","unstructured":"Landau SM, Breault C, Joshi AD, et al. Amyloid-\u03b2 imaging with Pittsburgh compound B and Florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013;54:70\u20137. https:\/\/doi.org\/10.2967\/jnumed.112.109009.","journal-title":"J Nucl Med"},{"key":"7233_CR10","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49:3508\u201328. https:\/\/doi.org\/10.1007\/s00259-022-05784-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7233_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1471-4159.2010.06812.x","volume":"114","author":"A Jur\u00e9us","year":"2010","unstructured":"Jur\u00e9us A, Swahn BM, Sandell J, et al. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J Neurochem. 2010;114:784\u201394. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06812.x.","journal-title":"J Neurochem"},{"key":"7233_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2967\/jnumed.112.114785","volume":"54","author":"CC Rowe","year":"2013","unstructured":"Rowe CC, Pejoska S, Mulligan RS, et al. Head-to-head comparison of 11\u00a0C-PiB and 18F-AZD4694 (NAV4694) for \u03b2-amyloid imaging in aging and dementia. J Nucl Med. 2013;54:880\u20136. https:\/\/doi.org\/10.2967\/jnumed.112.114785.","journal-title":"J Nucl Med"},{"key":"7233_CR13","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1021\/acs.jmedchem.2c01503","volume":"66","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou K, Zhang X, et al. Fluorine-18-Labeled Diaryl-azines as improved \u03b2-Amyloid imaging tracers: from bench to First-in-Human studies. J Med Chem. 2023;66:4603\u201316. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01503.","journal-title":"J Med Chem"},{"key":"7233_CR14","doi-asserted-by":"publisher","first-page":"120779","DOI":"10.1016\/j.neuroimage.2024.120779","volume":"298","author":"M Wu","year":"2024","unstructured":"Wu M, Ren C, Mao C, et al. Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer\u2019s disease diagnosis and \u03b2-amyloid deposition quantification. NeuroImage. 2024;298:120779. https:\/\/doi.org\/10.1016\/j.neuroimage.2024.120779.","journal-title":"NeuroImage"},{"issue":"32","key":"7233_CR15","doi-asserted-by":"publisher","first-page":"34675","DOI":"10.1021\/acsomega.4c03412","volume":"9","author":"M Ni","year":"2024","unstructured":"Ni M, Zhu X, Wang K, et al. Novel \u03b2-amyloid PET imaging study of [18F]92 in patients with cognitive decline. ACS Omega. 2024;9(32):34675\u201383. https:\/\/doi.org\/10.1021\/acsomega.4c03412.","journal-title":"ACS Omega"},{"key":"7233_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acsptsci.4c00149","volume":"7","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang X, Zhao H, et al. Screening of [18F]Florbetazine for A\u03b2 plaques and a Head-to-Head comparison study with [11\u00a0C]Pittsburgh Compound-B ([11\u00a0C]PiB) in human subjects. ACS Pharmacol Transl Sci. 2024;7:2054\u201362. https:\/\/doi.org\/10.1021\/acsptsci.4c00149.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"7233_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3233\/JAD-220194","volume":"87","author":"L Dong","year":"2022","unstructured":"Dong L, Liu C, Sha L, et al. PSEN2 mutation spectrum and novel functionally validated mutations in Alzheimer\u2019s disease: data from PUMCH dementia cohort. J Alzheimers Dis. 2022;87:1549\u201356. https:\/\/doi.org\/10.3233\/JAD-220194.","journal-title":"J Alzheimers Dis"},{"key":"7233_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-141278","volume":"43","author":"JP Tan","year":"2015","unstructured":"Tan JP, Li N, Gao J, et al. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal cognitive assessment among elderly and oldest-old Chinese population. J Alzheimers Dis. 2015;43:1403\u201312. https:\/\/doi.org\/10.3233\/JAD-141278.","journal-title":"J Alzheimers Dis"},{"key":"7233_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, et al. In vivo imaging of amyloid deposition in alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51:913\u201320. https:\/\/doi.org\/10.2967\/jnumed.109.069088.","journal-title":"J Nucl Med"},{"key":"7233_CR20","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, et al. The role of amyloid PET in imaging neurodegenerative disorders: A review. J Nucl Med. 2022;63:S13\u20139. https:\/\/doi.org\/10.2967\/jnumed.121.263195.","journal-title":"J Nucl Med"},{"key":"7233_CR21","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959\u201372.","journal-title":"J Nucl Med"},{"key":"7233_CR22","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.110.076315","volume":"52","author":"CC Rowe","year":"2011","unstructured":"Rowe CC, Villemagne VL. Brain amyloid imaging. J Nucl Med. 2011;52:1733\u201340. https:\/\/doi.org\/10.2967\/jnumed.110.076315.","journal-title":"J Nucl Med"},{"key":"7233_CR23","doi-asserted-by":"publisher","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Sr, et al. The centiloid project: standardizing quantitative amyloid plaque Estimation by PET. Alzheimers Dement. 2015;11:1\u201315. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003..e1-4.","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"7233_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","volume":"14","author":"M Navitsky","year":"2018","unstructured":"Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, et al. Standardization of amyloid quantitation with Florbetapir standardized uptake value ratios to the centiloid scale. Alzheimers Dement. 2018;14:1565\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.1353.","journal-title":"Alzheimers Dement"},{"key":"7233_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2967\/jnumed.123.265766","volume":"65","author":"WJ Jagust","year":"2024","unstructured":"Jagust WJ, Mattay VS, Krainak DM, et al. Quantitative brain amyloid PET. J Nucl Med. 2024;65:670\u20138. https:\/\/doi.org\/10.2967\/jnumed.123.265766.","journal-title":"J Nucl Med"},{"key":"7233_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jalz.2015.06.036","volume":"11","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Bourgeat P, Dor\u00e9 V, et al. Amyloid imaging in therapeutic trials: the quest for the optimal reference region [abstract]. Alzheimers Dement. 2015;11:21\u20132. https:\/\/doi.org\/10.1016\/j.jalz.2015.06.036.","journal-title":"Alzheimers Dement"},{"key":"7233_CR27","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1002\/alz.13883","volume":"20","author":"M Shekari","year":"2024","unstructured":"Shekari M, V\u00e1llez Garc\u00eda D, Collij LE, et al. Stress testing the centiloid: precision and variability of PET quantification of amyloid pathology. Alzheimers Dement. 2024;20:5102\u201313. https:\/\/doi.org\/10.1002\/alz.13883.","journal-title":"Alzheimers Dement"},{"key":"7233_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73:1193\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bc010c.","journal-title":"Neurology"},{"key":"7233_CR29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ana.23908","volume":"74","author":"SM Landau","year":"2013","unstructured":"Landau SM, Lu M, Joshi AD, et al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid. Ann Neurol. 2013;74:826\u201336. https:\/\/doi.org\/10.1002\/ana.23908.","journal-title":"Ann Neurol"},{"key":"7233_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s10741-021-10183-w","volume":"27","author":"S Saeed","year":"2022","unstructured":"Saeed S, Saad JM, Ahmed AI, et al. The utility of positron emission tomography in cardiac amyloidosis. Heart Fail Rev. 2022;27:1531\u201341. https:\/\/doi.org\/10.1007\/s10741-021-10183-w.","journal-title":"Heart Fail Rev"},{"key":"7233_CR31","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","volume":"13","author":"S Dorbala","year":"2020","unstructured":"Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: a practical approach. JACC Cardiovasc Imaging. 2020;13:1368\u201383. https:\/\/doi.org\/10.1016\/j.jcmg.2019.07.015.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7233_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N, Katoh N, Oguchi K, et al. Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11\u00a0C-PiB PET imaging. Eur J Nucl Med Mol Imaging. 2018;45:452\u201361. https:\/\/doi.org\/10.1007\/s00259-017-3814-1.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07233-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07233-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07233-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:08:46Z","timestamp":1754356126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07233-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7233"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07233-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of PUMCH (I-22YJ221) and registered at ClinicalTrials.gov (NCT06141356).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all subjects or their caregivers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}